Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma
Clinical trial NCT01637753 · UNKNOWN
Trial details
- NCT number
- NCT01637753
- Sponsor
- Shandong Lanjin Pharmaceuticals Co.,Ltd
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2013-06-01
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.